"OUTFRONT has always believed in the unique power and influence of out-of-home to shape culture and drive results," said Nick...
Mark
Mark F. Kubik BOSTON and LONDON, May 01, 2025 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology...
Akari Therapeutics (NASDAQ: AKTX) has appointed Mark F. Kubik as Head of...
